Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary (Review)

By      

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 571-576

Spandidos Publications

Access to resources Recommend Favorite

Combining DNA Damaging Agents and Checkpoint 1 Inhibitors

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 5, 2004-09 ,pp. : 435-438

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis of Cis-Fused Pyran Indolocarbazole Derivatives that Inhibit FLT3 Kinase and the DNA Damage Kinase, Checkpoint Kinase 1

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 3, 2012-01 ,pp. : 194-201

Bentham Science Publishers

Access to resources Recommend Favorite

Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability

By Shin H.-J.   Baek K.-H.   Jeon A.-H.   Park M.-T.   Lee S.-J.   Kang C.-M.   Lee H.-S.   Yoo S.-H.   Chung D.-H.   Sung Y.-C.   McKeon F.   Lee C.-W.  

Cancer Cell, Vol. 4, Iss. 6, 2003-12 ,pp. : 483-497

Elsevier

Access to resources Recommend Favorite

5-FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53-mutated colon cancer cells

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 63-70

Spandidos Publications

Access to resources Recommend Favorite